RecruitingNCT04604990

National Systemic Lupus Erythematosus Prospective Cohort, Saudi Arabia


Sponsor

King Saud University

Enrollment

1,000 participants

Start Date

Dec 20, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

SLE disease in Saudi Arabia is yet not well defined especially in a population with high consanguinity and high inbreeding coefficient . Up until now, there has been no prospective cohort study for SLE patients in Saudi Arabia. As a result, current published literature is focused on retrospective chart reviews which are subjected to many forms of bias. so the investigator proposed this prospective registry which will follow open cohort study design aiming to provide better understanding of disease presentation, course and outcomes especially if complemented by detailed immunological, molecular, genetic and microbiome data.


Eligibility

Min Age: 19 Years

Inclusion Criteria3

  • Adult patients defined as age greater than 18 years old.
  • Patients should fulfil one of the following classification criteria for SLE (ACR, SLICC or ACR/EULAR criteria).
  • No restriction on time of diagnosis.

Exclusion Criteria1

  • Patients who don't fulfil classification criteria mentioned above.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

king Saud University medical city

Riyadh, Central Province, Saudi Arabia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04604990


Related Trials